Management of Acute Myeloid Leukemia in 2020: A Paradigm Shift for Older Adults?
Dr. Joshua Zeidner will discuss updates in the diagnostic testing and prognostic subclassifications of AML which drive therapeutic decisions. This presentation will highlight perceived paradigm shifts for AML and older adults.
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.
- Discuss pathogenesis/etiology of AML
- Explain diagnostic testing in AML
- Describe management of AML in older patient populations in the context of recent drug approvals
Joshua Zeidner, MD
Presenter Disclosure Information
Joshua Zeidner, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.
The Greensboro Area Health Education Center is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Approved by the UNC Eshelman School of Pharmacy for ACPE.
Approved by the American Society of Radiologic Technologists (ASRT).
The UNC School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation
UNC Lineberger Cancer Network certificate of participation.
Tim Poe, Director of Telehealth